Astera Labs (NASDAQ:ALAB) Shares Up 2.6% - Still a Buy?

Key Points

• Astera Labs shares rose 2.6% to $296.98, while trading volume was 57% below the average. The stock has a $51.52 billion market capitalization and trades at a high P/E ratio of 147.02.
• Analyst sentiment remains favorable, with a consensus rating of “Moderate Buy” and an average price target of $340.53; recent targets range from $280 to $375.
• The company exceeded quarterly expectations, reporting $0.80 in EPS and $392.4 million in revenue, up 104.5% year over year. However, insiders have sold $163.1 million of stock over the past 90 days, including sales by the COO and a director.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares traded up 2.6% on Monday . The company traded as high as $297.95 and last traded at $296.98. Approximately 2,314,614 shares traded hands during trading, a decline of 57% from the average daily volume of 5,348,212 shares. The stock had previously closed at $289.47.

Analysts Set New Price Targets

A number of research firms have recently commented on ALAB. Morgan Stanley raised their price objective on shares of Astera Labs to $335.00 and gave the stock an "overweight" rating in a report on Monday, August 3rd. Zacks Research raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 11th. JPMorgan Chase & Co. increased their price target on shares of Astera Labs from $205.00 to $280.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 6th. Barclays raised their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research note on Monday, July 20th. Finally, TD Cowen lowered their price objective on Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat, Astera Labs has an average rating of "Moderate Buy" and an average target price of $340.53.

Astera Labs Trading Up 2.6%

The firm has a market cap of $51.52 billion, a P/E ratio of 147.02 and a beta of 3.84. The company's fifty day moving average price is $342.38 and its two-hundred day moving average price is $250.08.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company's revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the firm's stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the sale, the director owned 3,970 shares of the company's stock, valued at approximately $1,237,965.10. This trade represents a 69.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 419,244 shares of company stock worth $163,135,169 over the last 90 days. Company insiders own 10.40% of the company's stock.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently added to or reduced their stakes in the stock. Greenleaf Trust lifted its holdings in shares of Astera Labs by 1.8% in the second quarter. Greenleaf Trust now owns 2,000 shares of the company's stock valued at $966,000 after purchasing an additional 36 shares in the last quarter. Glenmede Trust Co. NA grew its holdings in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company's stock worth $209,000 after buying an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. bought a new position in shares of Astera Labs during the second quarter worth about $25,000. Lido Advisors LLC raised its position in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company's stock valued at $2,046,000 after buying an additional 57 shares during the last quarter. Finally, Archer Investment Corp acquired a new stake in Astera Labs in the 2nd quarter valued at approximately $30,000. Institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source